1,977 reports of this reaction
1.8% of all METFORMIN HYDROCHLORIDE TABLET reports
#10 most reported adverse reaction
OFF LABEL USE is the #10 most commonly reported adverse reaction for METFORMIN HYDROCHLORIDE TABLET, manufactured by EPIC PHARMA, LLC. There are 1,977 FDA adverse event reports linking METFORMIN HYDROCHLORIDE TABLET to OFF LABEL USE. This represents approximately 1.8% of all 107,050 adverse event reports for this drug.
Patients taking METFORMIN HYDROCHLORIDE TABLET who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is a less commonly reported adverse event for METFORMIN HYDROCHLORIDE TABLET, but still significant enough to appear in the safety profile.
In addition to off label use, the following adverse reactions have been reported for METFORMIN HYDROCHLORIDE TABLET:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 1,977 FDA reports for METFORMIN HYDROCHLORIDE TABLET. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 1.8% of all adverse event reports for METFORMIN HYDROCHLORIDE TABLET, making it a notable side effect.
If you experience off label use while taking METFORMIN HYDROCHLORIDE TABLET, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.